Currency-battered Roche says launches will boost sales
This article was originally published in Clinica
Executive Summary
Roche Diagnostics is hoping that new product launches - some of which will come from its recent noteworthy partnerships - will help bring its sales up to double-digit growth (disregarding exchange rate effects) later this year. Its first-quarter revenues are not yet meeting the mark, however. They rose by 7% in local currencies, and unfavourable exchange rates led to a reported drop of 3%.